High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes

References

• Lee SH, Kwon JE, Cho M-L. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26–42.
   PubMed Web of Science ®Google Scholar
• Shouval DS, Rufo PA. The role of environmental factors in the pathogenesis of inflammatory bowel diseases: a review. JAMA Pediatr. 2017;171(10):999–1005.
   PubMed Web of Science ®Google Scholar
• Wu P, Jia F, Zhang B, et al. Risk of cardiovascular disease in inflammatory bowel disease (Review). Exp Ther Med. 2017;13(2):395–400.
   PubMed Web of Science ®Google Scholar
• Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22(20):4794–4801.
   PubMed Web of Science ®Google Scholar
• Shah YM. The role of hypoxia in intestinal inflammation. Mol Cell Pediatr. 2016;3(1):1.
   PubMedGoogle Scholar
• Rohm I, Ratka J, Pistulli R, et al. Impact of systemic normobaric short-term hypoxia on pro-inflammatory and anti-inflammatory cytokines in healthy volunteers. Clin Lab. 2015;61:1053–1059.
   PubMed Web of Science ®Google Scholar
• Baldi S, Pinna GD, Mombaruzzo P, et al. C-reactive protein correlates with tissue oxygen availability in patients with stable COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:745–751.
   PubMedGoogle Scholar
• Biddlestone J, Bandarra D, Rocha S. The role of hypoxia in inflammatory disease (Review). Int J Mol Med. 2015;35(4):859–869.
   PubMed Web of Science ®Google Scholar
• Luo H, Zhou DJ, Chen Z, et al. Establishment and evaluation of an experimental rat model for high-altitude intestinal barrier injury. Exp Ther Med. 2017;13(2):475–482.
   PubMed Web of Science ®Google Scholar
• Li M, Han T, Zhang W, et al. Simulated altitude exercise training damages small intestinal mucosa barrier in the rats. J Exerc Rehabil. 2018;14(3):341–348.
   PubMed Web of Science ®Google Scholar
• Zheng L, Kelly CJ, Colgan SP. Physiologic hypoxia and oxygen homeostasis in the healthy intestine. A review in the Theme: cellular responses to hypoxia. American Journal of Physiology-Cell Physiology. 2015;309:C350–C60.
   PubMed Web of Science ®Google Scholar
• Anand AC, Sashindran VK, Mohan L. Gastrointestinal problems at high altitude. Tropical gastroenterology: official journal of the Digestive Diseases Foundation. 2006;27:147–153.
   PubMedGoogle Scholar
• TY W, SQ D, JL L, et al. High-altitude gastrointestinal bleeding: an observation in Qinghai-Tibetan railroad construction workers on Mountain Tanggula. World J Gastroenterol. 2007;13(5):774–780.
   PubMed Web of Science ®Google Scholar
• Vavricka SR, Rogler G, Biedermann L. High altitude journeys, flights and hypoxia: any role for disease flares in IBD patients? Dig Dis. 2016;34(1–2):78–83.
   PubMed Web of Science ®Google Scholar
• Lippl FJ, Neubauer S, Schipfer S, et al. Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity (Silver Spring, MD). 2010;18(4):675–681.
   PubMed Web of Science ®Google Scholar
• Basnyat B. Hypobaric hypoxia. Seminar. 2001;357:956.
   Google Scholar
• Cosin-Roger J, Simmen S, Melhem H, et al. Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation. Nat Commun. 2017;8(1):98.
   PubMedGoogle Scholar
• Khanna K, Mishra KP, Chanda S, et al. Effect of synbiotics on amelioration of intestinal inflammation under hypobaric hypoxia. High Alt Med Biol. 2021;22(1):32–44.
   PubMed Web of Science ®Google Scholar
• Cao Y, Lin Y, Sun Y, et al. Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium. Bioengineered. 2021;12(1):151–161.
   PubMed Web of Science ®Google Scholar
• Marini M, Bamias G, Rivera-Nieves J, et al. TNF-alpha neutralization ameliorates the severity of murine Crohn’s-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc Natl Acad Sci U S A. 2003;100(14):8366–8371.
   PubMed Web of Science ®Google Scholar
• Whittem CG, Williams AD, Williams CS 2010. Murine colitis modeling using dextran sulfate sodium (DSS). J Vis Exp. 35. DOI: 10.3791/1652.
   PubMedGoogle Scholar
• Alahdal M, Xing Y, Tang T, et al. 1-Methyl-D-tryptophan reduces tumor CD133(+) cells, Wnt/β-catenin and NF-κβp65 while enhances lymphocytes NF-κβ2, STAT3, and STAT4 pathways in murine pancreatic adenocarcinoma. Sci Rep. 2018;8(1):9869.
   PubMedGoogle Scholar
• SE B, AS S, Löwenberg M, et al. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of ulcerative colitis. Clin Pharmacokinet. 2019;58:15–37.
   PubMed Web of Science ®Google Scholar
• Liu S, Shen H, Li J, et al. Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-κB signaling pathway to attenuate ulcerative colitis. Bioengineered. 2020;11(1):628–639.
   PubMed Web of Science ®Google Scholar
• Gong Y, Niu W, Tang Y, et al. Aggravated mucosal and immune damage in a mouse model of ulcerative colitis with stress. Exp Ther Med. 2019;17:2341–2348.
   PubMed Web of Science ®Google Scholar
• Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes Infect. 2017;19:210–221.
   PubMed Web of Science ®Google Scholar
• Wells RMG, Webster MED. Age-related changes in haemoglobin-oxygen affinity and haematology of rats at high altitude. Comparative Biochem Physiol Part A. 1979;62(4):927–931.
   Google Scholar
• Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23(33):6016–6029.
   PubMed Web of Science ®Google Scholar
• Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PloS One. 2009;4(6):e6073.
   PubMed Web of Science ®Google Scholar
• Å H, Tormo-Badia N, Baridi A, et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin Exp Med. 2015;15(1):107–120.
   PubMed Web of Science ®Google Scholar
• Nava P, Koch S, Laukoetter MG, et al. Interferon-γ regulates intestinal epithelial homeostasis through converging β-catenin signaling pathways. Immunity. 2010;32(3):392–402.
   PubMed Web of Science ®Google Scholar
• Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140(6):1729–1737.
   PubMed Web of Science ®Google Scholar
• Mankertz J, Schulzke J-D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007;23(4):379–383.
   PubMed Web of Science ®Google Scholar
• Toedter G, Li K, Sague S, et al. Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy. Inflamm Bowel Dis. 2012;18(8):1399–1410.
   PubMed Web of Science ®Google Scholar
• Dang Eric E, Barbi J, Yang H-Y, et al. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell. 2011;146(5):772–784.
   PubMed Web of Science ®Google Scholar
• Xue G, Hua L, Zhou N, et al. Characteristics of immune cell infiltration and associated diagnostic biomarkers in ulcerative colitis: results from bioinformatics analysis. Bioengineered. 2021;12(1):252–265.
   PubMed Web of Science ®Google Scholar
• Moschen AR, Tilg H, Raine T. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat Clin Pract Gastroenterol Hepatol. 2019;16(3):185–196.
   Google Scholar
• Melgar S, Yeung MMW, Bas A, et al. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol. 2003;134(1):127–137.
   PubMed Web of Science ®Google Scholar
• Wu J, Cui H, Zhu Z, et al. Effect of HIF1α on Foxp3 expression in CD4+ CD25−T lymphocytes. Microbiol Immunol. 2014;58(7):409–415.
   PubMed Web of Science ®Google Scholar